Bone Marrow TransplantationTransplantation, HomologousBone MarrowGraft vs Host DiseaseBone Marrow CellsWhole-Body IrradiationLeukemiaAnemia, AplasticTransplantation ConditioningTissue DonorsTransplantation, AutologousTransplantation ChimeraBone and BonesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft SurvivalCytomegalovirus InfectionsHematopoietic Stem Cell TransplantationHematologic NeoplasmsLeukemia, Myeloid, AcuteLymphocyte DepletionImmunosuppressive AgentsRecurrenceHistocompatibility TestingBusulfanPrecursor Cell Lymphoblastic Leukemia-LymphomaHistocompatibilityHematopoietic Stem CellsTime FactorsLymphocyte TransfusionNuclear FamilyAcute DiseaseT-LymphocytesRemission InductionCombined Modality TherapyBone Marrow PurgingRadiation ChimeraCyclosporineTreatment OutcomeTransplantation, IsogeneicCyclophosphamideMice, Inbred C57BLGraft vs Host ReactionHematopoiesisLeukocyte TransfusionImmunosuppressionBone Marrow DiseasesGraft RejectionSurvival AnalysisRetrospective StudiesCytomegalovirusLeukemia, MyeloidGraft vs Tumor EffectHepatic Veno-Occlusive DiseaseBone Marrow ExaminationBone RemodelingKidney TransplantationChimeraMyelodysplastic SyndromesHLA AntigensBone Marrow NeoplasmsLiver TransplantationHematologic DiseasesTransplantation ImmunologyGraft vs Leukemia EffectLymphoma, Non-HodgkinColony-Forming Units AssayFatal OutcomeImmunocompromised HostMice, Inbred BALB CFlow CytometryLeukocyte CountOpportunistic InfectionsActuarial AnalysisSevere Combined ImmunodeficiencySpleenBone DensityCells, CulturedSurvival RateStem Cell TransplantationGranulocyte Colony-Stimulating FactorCell DifferentiationFollow-Up StudiesBlood CellsAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationLymphocytesAntigens, CD34Disease-Free SurvivalPolymerase Chain ReactionMultiple MyelomaPneumonia, ViralImmunophenotypingAntilymphocyte SerumBone ResorptionPancytopeniaGanciclovirHeart TransplantationInfectionAntibodies, MonoclonalAntigens, CD